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Introduction
Gynecological malignancies contribute substantially 
to female mortality and morbidity. According to a study 
in 2006 uterine malignancies accounted for 41,200 newly 
diagnosed cases, ovarian malignancies for 20,180 and 
cervical malignancies for 9,710 cases. (Bankhead et al., 
2008).
There is paucity of local data for the prevalence 
of endometrial malignancy however according to 
Karachi Cancer Registry statistics, female genital tract 
malignancies including ovaries, cervix and endometrium 
contributes 13% of all types of cancers in females. 
(Yasmin et al., 2006). In the advanced nations carcinoma 
of endometrium is the most common cancer of female 
genital organs. Most of these cancers detected while 
restricted to the uterus and usually presented with post-
menopausal per vaginal hemorrhagic discharge or frank 
bleeding. (Wanitcharand Mongkol, 2012).
Ovarian malignancy causes more deaths than any other 
gynecological cancers and is the leading cause of death 
from cancer of female reproductive system. (Jelovac et 
al., 2011). In the United States, ovarian malignancy is 
the seventh most common cancer and accounting for 6% 
of deaths from malignancy in females. At the time of 
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Abstract
 Objective: To determine the accuracy of magnetic resonance imaging (MRI) in detection of metastasis in 
pelvic and para-aortic lymph nodes from different gynecological malignancies. Materials and Methods: This 
retrospective cross sectional analytic study was conducted at the Department of Diagnostic Radiology, Aga 
Khan University Hospital Karachi Pakistan from January 2011 to December 2012. A sample of 48 women, age 
range between 20-79 years, fulfilling inclusion criteria were included. All patients had histopathologically proven 
gynecological malignancies in the cervix, endometrium or ovary and presented for a pretreatment MRI to our 
radiology department. Results: MRI was 100% sensitive and had a 100% positive predictive value to detect lymph 
node metastasis in lymph nodes with spiculated margins and 100% sensitive with a 75% positive predictive value 
to detect lymph node metastasis in a lymph node with lobulated margins. The sensitivity and positive predictive 
value of MRI to detect heterogeneous nodal enhancement were 100% and 75% respectively. Conclusions: Our 
study results reinforce that MRI should be used as a modality of choice in the pretreatment assessment of lymph 
nodes in proven gynaecological malignancies in order to determine the line of patientmanagement, distinguishing 
surgical from non-surgical cases. 
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diagnosis more than two thirds of females have progressive 
malignancy. Ovarian malignancy has the highest fatality-
to-case ratio of all the cancers of female genital tract. 
(Bandit, 2013). In 1998 an estimated 25200 new cases of 
ovarian cancerand 14500 demises were documented in 
United States. (Li-Na et al., 2013). According to National 
Cancer Registry Programme of Indian Council Medical 
Resrearch, proportion of ovarian malignancy had a range 
from 1.7% to 8.7% of all malignancies related to female 
genital tract in all populations including pastoral and 
metropolitan people. (Nandagudi et al., 2009).
The cervical malignancy is a gradual and slow 
growing tumor and PAP smear and HPV DNA test are the 
screening tools. (JVJoshi et al., 2011). Cervical infection 
by HPV 16 AND 18 is the main etiological factor of 
cervical malignancy. (Nabiha et al., 2010). Globaly, the 
great prevalence of cervical malignancy is related to the 
deficiency of cervical cancer screening and lost follow up 
of cervical diseases. (Muhammad et al., 2009).
Metastatic involvement of lymph nodes from 
gynecological malignancies is a poor prognostic sign 
like in cervical malignancies metastatic involvement of 
para-aortic lymph node is an indication of bad prognosis 
( Tanaka et al., 1984; Takeshima et al., 1999). In such 
cases nodal resection before commencing the radiotherapy 
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results in a better survival rate. (Potish et al., 1985; 
Downey et al., 1989).
The accurate assessment of metastatic involvement 
of lymph nodes is one of the most significant challenges 
in cancer imaging today. Pretreatment assessment of 
metastatic lymph nodes determines the line of patient’s 
management, basically distinguishing surgical from non-
surgical cases. (Morch et al., 2012).
Advanced stages of gynecological malignancies with 
a bulk of primary tumor have greater chances to have 
metastatic lymph nodes. (Melin et al., 2007) Rate of 
recurrence and overall survival are directly related to the 
nodal spread of the disease. Magnetic resonance imaging 
(MRI) is an excellent modality in identification of pelvic 
lymph nodes, their location and detection of their possible 
involvement by the primary disease. Lymph node size, 
shape and post contrast enhancement are a useful criteria 
for MRI assessment of lymph nodes. A lymph node should 
be regarded as enlarged on MRI if it is more than 8 mm 
in maximum short axis diameter (MSAD). (Barentszet 
al., 1999). 
In table1, according to two recent studies, normal 
MSAD of lymph node on MRI is given. (Vinnicombeet 
al., 1995; Grubnicet al., 2002).
According to several studies, rounded lymph nodes 
are more likely to be malignant (Potish et al., 1985) 
and ill-defined and irregular nodal margins are features 
suggestive of malignancy.
Bondt et al. has well described the morphological 
criteria of lymph nodes on MRI (Figure. 1). Smooth 
lymph node has well defined and smooth walls without 
any irregularity or lobulation. Lobulated lymph nodes 
are smooth walled but has lobulated margins. Spiculated 
lymph nodes are nodes having irregular margins with 
spikes or vegetation. Indistinct lymph nodes are nodes 
with margins which are difficult to appreciate. (R. B. J. 
de Bondt et al., 2009; Goro et al., 2013). In this study 
we used lymph node margins and enhancement pattern 
as the criteria.
Materials and Methods
The data was collected retrospectively from patient’s 
medical records. The study was conducted at the 
Department of Diagnostic Radiology Aga Khan Hospital 
University. The study duration was from January 2011 to 
December 2012, the age range was from 20 to 79 years 
(mean age 55 years).
In clusion criteria
 Patients with histopathologically proven carcinoma 
endometrium, cervix and ovary with complete medical 
record were included in the study. All patient had pre-
operative MRI of pelvis and lower abdomen.
Exclusion criteria
Patients were excluded, who had evidence of distance 
metastasis or had contraindication to surgical procedure 
(i.e. unfit for surgery or anesthesia due to any reason), 
were also excluded if the patients were not to undergo 
laproscopic dissection of lymph nodes.
MRI protocol
Before commencing the MRI scanning, an informed 
consent was taken. MRI pelvis was done on the Siemen’s 
1.5 T system using a torso phased - array coil for the 
abdominal scan and pelvic array coil for the pelvic scan.
T1-T2 sagittal, axial and coronal images were obtained 
with slice thickness of 4 mm, Intravenous Gadolinium was 
given in a dose of 0.2 mmol/kg. Images were taken from 
symphysis pubis upwards to the level of iliac blades in 
axial sections; however in coronal scanning para-aortic 
region was included up to the level of renal hilum.
According to anatomical landmark lymph nodes were 
classified in 7 groups: bilateral para aortic region, bilateral 
common iliac region, bilateral external iliac region, and 
bilateral internal iliac region and bilateral obturator region.
Surgical technique
Pre operative bowel preparations and prophylactic 
antibiotics were given for 48 hours to all patients. During 
surgery, lymph nodes dissection of para aortic region 
and lymph nodes of pelvic region was done through 
laparotomy /laproscopic surgery.
Histopathological techniques and assessment of Lymph 
Node
Histopathological evaluation of the lymph nodes was 
taken as a Gold Standard. Thin section of given lymph 
node were taken, each lymph node was sliced at 2 mm 
intervals All lymph nodes were stained with H & E, and 
assessed via microscope by a pathologist with 5 years of 
experience.
MRI analysis
During MRI analysis, two consultant radiologists with 
at least 5 years of experience in female imaging, evaluated 
all the scans. They were unaware of the histopathological 
diagnosis of lymph nodes.
All visible lymph nodes were thoroughly inspected. 
Lymph nodes identified on MRI were recorded in 
terms of following features: i) Short - axis diameter. ii) 
Shape (rounded, oval, elongated). iii) Margins (smooth, 
lobulated, spiculated). iv). Post contrast enhancement 
pattern(homogenous, heterogeneous)
Axial T2 weighted fast spin echo sequences were 
used to assess the short axis diameter, shape and 
margins of lymph nodes. PACS (Picture Archiving and 
Communication System) monitor with electronic calipers 
were used for lymph node diameter measurements. Post 
contrast enhancement patterns either homogenous or 
heterogeneous were investigated on Gadolinium enhanced 
axial and coronal T1 weighted turbo spin echo sequences.
During short axis diameter evaluation, shape, margins 
and contrast enhancement pattern on MRI, it was difficult 
to assess the individual lymph node involved by the 
metastases on histopathology, as it was not possible to 
catch particular lymph node on MRI which one was 
malignant on histopathology. This limitation could be 
due to motion artifact and particular lymph node on MRI 
can be missed even with slice thickness of 4mm. We used 
number of positive or negative lymph nodes in MRI in 
each particular location and compared it with number of 
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positive or negative lymph node in this location of each 
patient.
Statistics
Data was recorded on Performa for every patient. 
Sensitivity, specificity, positive predictive value and 
diagnostic accuracies were calculated using SPSS version 
19. The Pearson’s chi square test was used to compare 
the post contrast enhancement pattern and lymph node 
margins. A p value of less than 0.05 was considered to 
indicate a statistically significant difference.
Results 
Histopathological examination confirmed metastatic 
lymph nodes in 3 (6.25%) of the 48 patients. Total of 196 
lymph nodes were identified on MRI and histopathology 
of all lymph nodes were obtained, only 26 were found to 
be malignant on histopathology. MRI showed in total 196 
lymph nodes, the mean short axis diameter of metastatic 
lymph node was larger (6.16 +/- 3.0 mm, n= 26) than that 
of non- metastatic lymph node (4.40 +/-3.0 mm, n= 180) 
p=0.027. The number of lymph nodes sampled in each 
patient during surgery ranged from 1-37. Oval shaped 
and elongated lymph nodes are more likely to be non-
metastatic however rounded nodes having equal chances 
to be metastatic and non-metastatic (p=0.001) (Table 2)
Lymph node with a lobulated margins (n=12) out of 
196 detectable lymph nodes on M.R.I showed sensitivity 
and positive predictive values of 100% and 75% 
respectively, lymph node with spiculations (n= 3) showed 
both sensitivity and positive predictive value of 100% 
so they are reliable indicators of lymph node metastasis 
(p=0.000) Table2.
MRI with Gadolinium- enhanced T1 weighted 
images was performed on all patients. As heterogeneous 
enhancement was more commonly seen in metastatic 
lymph nodes (6/14 {42%}) than in non-metastatic lymph 
nodes (2/181 {1.1%}) and this difference was found 
to be statistically significant (0.000) (Table 2). The 
sensitivity and positive predictive value of heterogeneous 
enhancement were 100% and 75% respectively.
Discussion
The application of advanced radiological modalities 
including MRI has been growing since 1980s and 
supplanting the other interventional imaging and invasive 
procedures. These advanced imaging modalities are 
necessary for accurate pretreatment staging as they are 
more informative than physical examination and provide 
details of lymph nodes metastases apart from tumor size 
and local invasion. (Janjira et al., 2012).
According to few studies, lymph nodes evaluation by 
MRI is still not an easy task, Study by Bipat et al showed 
that, for identifying nodal metastasis radiological tools 
including MRI and CT scan are not sufficiently accurate 
and that’s why evaluation of nodal metastases remains a 
challenge. (Bipat et al., 2004).
Another study by Lambregts et al showed that MRI has 
an advantage of high tissue contrast but still for evaluation 
of nodal metastases it showed under staging up to 16%. 
(Lambregts et al., 2011). Furthermore, a few of these 
advanced modalities are still inaccessible in developing 
areas like China. (Chun et al., 2013).
However according another large group of studies, 
the accuracy and sensitivity rates for MRI are higher, 
i.ebetween 76 and 100% and 36% and 89.5% respectively. 
(Togashi et al., 1986; Waggenspack et al., 1988; Togashi 
et al., 1989; Outwater et al., 1992; Kim et al., 1994; Yu et 
al., 1998; Yang et al., 2000; Choi et al., 2004).
‘Lymph node positive’ on MRI or histopathology 
means lymph node is suspicious to have metastases and 
confirm to have metastases respectively. ‘Lymph node 
negative’ on MRI or histopathology means lymph node 
is benign looking and confirm to have no metastases 
respectively. 
Our results showed that lymph nodes with greater short 
axis diameter were malignant than lymph nodes with lesser 
short axis diameter (p=0.027), which is identical to the 
Table 1. Normal lymph Node Size on MRI 95th 
Percentile value-5% FP Rate
SITE MSAD in mm
Common iliac 4
External iliac 5
Obturator 4
Internal iliac 5
Table 2. Lymph Nodes Characteristics on MRI
MRI findings No (%) of lymph nodes
 Total  Metastatic Non-metastatic p
Shape    0.001
Rounded 55(28) 4(2.0) 5(2.55) 
Oval 18(9.1) 4(2.0) 14(7.14) 
Elongated 124(63.2) 1(0.5) 123(62.7) 
Margins    0.000
Smooth 183(93) 6(3.06) 177(90.3) 
Lobulated 12(6.1) 9(4.6) 3(1.5) 
Speculated 3(1.5) 3(1.5) 0(0) 
Enhancement    0.000
Homogenous 187(95) 8(4.08) 179(91.3) 
Hetrogenous 8(4) 6(3.06) 2(1.02) 
Table 3. Accuracy Profile of Morphological Criterion
MRI findings Sensitivity Specificity PPV Accuracy
Lobulated margins 100% 98% 75% 98%
Speculated Margins 100% 100% 100% 100%
Homogenous enhancement 100% 4% 4% 8%
Heterogonous enhancement 100% 98% 75% 98%
 
Figure 1. Morphological Features of Lymph Nodes (R. 
B. J. de Bondt et al., 2009)
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study done by Takeshima et al. and elongated and oval 
shaped lymph nodes were non malignant and rounded 
lymph nodes were equaly metastaic and non metastatic in 
our study (p=0.001) and it is more consistent than a study 
by Takeshima et al which showed p=0.0263. (Yasmin et 
al., 2006).
A study by Bipat et al showed higher sensitivity of MRI 
for lymph nodes assessment and almost similar specificity 
to CT scan, but these results were be influenced by short 
axis diameter criterion of lymph nodes. (Bipat et al., 2003; 
Janjira et al., 2012).
In our study, lymph nodes with lobulated margins on 
M.R.I showed sensitivity and positive predictive values of 
100% and 75% respectively, lymph node with spiculations 
both sensitivity and positive predictive value of 100% 
so they are reliable indicators of lymph node metastasis 
(p=0.000) this is more consistent than a study done by 
Takeshima et al, which showed sensitivity and positive 
predictive value on MRI to detect lymph node metastasis 
was 33.9% and 56.8%, respectively, this difference was 
probably due to size criteria which we did not apply but 
Takeshima et al.have applied both of these criteria that 
is, a short-axis diameter of 9 mm for the upper limit of 
a normal lymph node and spiculated/ lobulated margin. 
(Yasmin et al., 2006).
In our study, lymph nodes with lobulated margins on 
M.R.I showed sensitivity and positive predictive values of 
100% and 75% respectively, lymph node with spiculations 
both sensitivity and positive predictive value of 100% 
so they are reliable indicators of lymph node metastasis 
(p=0.000), our study showed higher accuracy of MRI than 
a study done by Choi at al. ho reported MRI sensitivity 
and positive predictive values of 21.0% and 46.4%, 
respectively, (p=0.044) for lobulated and spiculated lymph 
nodes. (Choi et al., 2006).
In our study heterogeneous enhancement was 
more commonly seen in metastatic lymph nodes and 
this difference was found to be statistically significant 
(p=0.000), sensitivity and positive predictive value 
of heterogeneous enhancement were 100% and 75% 
respectively. It is more significant than a study done by 
Choi et al. (2006) in which post contrast heterogeneous 
lymph node enhancement was also more commonly 
noted in metastatic lymph nodes but this difference was 
not found to be statistically significant (p=0.076). The 
sensitivity and positive predictive value of this criterion 
were 24.6% and 44.7%, respectively. Our study showed 
that postcontrast enhancement is the sensitive criterion in 
metastatic involvement evaluation of lymph nodes. This 
could be due to application of short axis diameter along 
with contrast enhancement criterion by choi et al and we 
were unable to apply the short axis diameter along with 
enhancement criterion.
In the present study we found that on MRI, lymph 
node margins either spiculated or lobulated were strong 
indicators of metastatic involvement of lymph nodes, 
although desmoplastic reaction or tumor infiltration 
into perinodal fat could be the cause of spiculations and 
lobulations of lymph nodes margins (Yang et al., 2000; 
Toita et al., 2010).
In the present study, MRI is 100% sensitive and has 
100% positive predictive value to detect lymph node 
metastasis with a spiculated margin node and MRI is 
100% sensitive and has 75% positive predictive value 
to detect lymph node metastasis with a lobulated margin 
node (Table 3)
In this study, application of the enhancement pattern 
criterion was helpful to distinguish metastasis from non-
metastatic nodes as the sensitivity and positive predictive 
value of heterogeneous enhancement were 100% and 75% 
respectively.
In this study, application of the long to short axis 
diameter ratio i.e shape criterion and maximum short axis 
diameter criterion resulted in low accuracy. This is most 
likely due to limited evaluation of the maximum cross 
section of lymph node on axial MRI and limitations of 
histopathological evaluation of a particular lymph node 
which was identified on M.R.I.
A limitation of the current study was the node by node 
comparison, which was also not possible in our set up, as 
obtaining the histology of individual lymph node identified 
on cross- sectional images is likely to remain exigent.
In conclusion, we found that margin lobulations, 
spiculations and heterogeneous post contrast enhancement 
of lymph node is correlated with lymph node metastasis 
in patient of gynecological malignancy. Address 
correspondence to Saira Naz Sufian.
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